Skip to content

Hamilton Lane HLNE Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options

Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options at other companies

Photronics logo
PhotronicsPLAB
$464K+209%
Zymeworks logo
ZymeworksZYME
$8.72M+1,029%
BancFirst Corporation logo
BancFirst CorporationBANF
$781K-12.3%
Trex Company logo
Trex CompanyTREX
$286K-4.7%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$19.48M+715%
Baxter International logo
Baxter InternationalBAX
$8M-20.0%

Other financials

Income statement

See full
Revenue$193.6M-2.2%
Net income$66.2M+31.0%
EPS (diluted)$1.48+9.4%

Balance sheet

See full
Cash & equivalents$348.0M+6.3%
Total debt$356.5M-3.2%
Total equity$915.2M+27.6%
Total assets$2.3B+36.4%

Cash flow

See full
Operating cash flow$103.0M+162%
CapEx$1.7M-49.3%
Free cash flow$101.2M+182%

Valuation

See full
Market cap$3.3B-32.2%

Profitability

See full
Net margin32.8%+2.3pp
FCF margin55.2%+14.7pp

Returns & leverage

See full
Return on equity30.5%-4.5pp
Debt / equity0.4×-0.1×

Where this comes from

Reported directly by Hamilton Lane in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: Hamilton Lane’s 10-K, filed May 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about Hamilton Lane's proceeds from issuance of shares under incentive and share based compensation plans including stock options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Hamilton Lane's proceeds from issuance of shares under incentive and share based compensation plans including stock options?
Hamilton Lane (HLNE) reported proceeds from issuance of shares under incentive and share based compensation plans including stock options of $728K in Q1 2026.
How has Hamilton Lane's proceeds from issuance of shares under incentive and share based compensation plans including stock options changed year-over-year?
Hamilton Lane's proceeds from issuance of shares under incentive and share based compensation plans including stock options decreased by 5.0% year-over-year, from $766K to $728K.
What is the long-term trend for Hamilton Lane's proceeds from issuance of shares under incentive and share based compensation plans including stock options?
Over 4 years (2022 to 2026), Hamilton Lane's proceeds from issuance of shares under incentive and share based compensation plans including stock options has grown at a 13.8% compound annual growth rate (CAGR), from $1.86M to $3.12M.